Research News

---

Topic: Screening and Testing (view all topics)

Tags for topic Screening and Testing:

• Biopsy
• Blood Cell Counts
• Blood Marker Tests
• Breast MRI
• Breast Physical Exam
• Breast Self-Exam
• Chest X-Rays
• Digital Tomosynthesis
• FISH Test
• Genetic Testing
• IHC Test
• Inform HER2 Dual ISH Test
• MammaPrint
• Mammography
• Molecular Breast Imaging
• Oncotype DX
• SPoT-Light HER2 CISH
• Thermography
• Ultrasound

View articles by month and year

• Needle Biopsy May Lead to Better Treatment Outcomes Than Open Biopsy

  Published on October 8, 2012 at 12:00 am

  • Tags: Biopsy

  A study has found that diagnosing breast cancer with a needle biopsy instead of a traditional open surgical biopsy is more efficient, less invasive, and may lead to better treatment outcomes.

• Breast Cancer’s Hormone Receptor and HER2 Status Can Change After Diagnosis

  Published on June 20, 2012 at 12:00 am

  • Tags: Locally Advanced-stage: Stage IIIB, Locally Advanced-stage: Stage IIIC, Metastatic/Advanced-stage: Stage IV, Progesterone Receptor Negative Cancer, Progesterone Receptor Positive Cancer, Estrogen Receptor Negative Cancer, Estrogen Receptor Positive Cancer, HER2/neu Positive Cancer, Metastatic, Non-Metastatic, Regional, Biopsy, FISH Test, IHC Test, Inform HER2 Dual ISH Test, SPoT-Light HER2 CISH, HER2/neu Negative Cancer, Luminal A, Luminal B, Triple Negative, and HER2 Overexpressing

  The characteristics of a breast cancer -- including hormone receptor status and HER2 status -- can change over time. These changes may happen because the cancer cells change themselves or because treat...

• Aggressive Screening Plan Not Needed After Benign Biopsy Results

  Published on May 8, 2012 at 12:00 am

  • Tags: Biopsy

  More aggressive breast cancer screening may not make sense after a benign abnormal area is biopsied; following standard breast cancer screening guidelines for women with average breast cancer risk is appropriate.

• Biopsy of Metastatic Cancer May Change Treatment Plan

  Published on June 7, 2010 at 12:00 am

  • Tags: Metastatic, Metastatic/Advanced-stage: Stage IV, Estrogen Receptor Negative Cancer, Estrogen Receptor Positive Cancer, HER2/neu Negative Cancer, HER2/neu Positive Cancer, Progesterone Receptor Negative Cancer, Progesterone Receptor Positive Cancer, Biopsy, Luminal A, Luminal B, Triple Negative, and HER2 Overexpressing

  Research suggests that a breast cancer's characteristics may change if the cancer metastasizes, so doing a biopsy on metastatic cancer may make sense in some cases.

• Biopsy of Metastatic Cancer Can Improve Treatment

  Published on March 18, 2009 at 12:00 am

  • Tags: Metastatic, Metastatic/Advanced-stage: Stage IV, Estrogen Receptor Negative Cancer, Estrogen Receptor Positive Cancer, HER2/neu Negative Cancer, HER2/neu Positive Cancer, Progesterone Receptor Negative Cancer, Progesterone Receptor Positive Cancer, Biopsy, Luminal A, Luminal B, Triple Negative, and HER2 Overexpressing

  In some cases, certain "personality" factors of recurrent metastatic breast cancer -- hormone-receptor status and HER2 status -- can be different from the original breast cancer, which may affect treatment decisions.

• 3-D Ultrasound Can Help Determine if Suspicious Areas are Cancer

  Published on October 21, 2008 at 12:00 am

  • Tags: Biopsy and Ultrasound

  A small, early study suggests that speed-weighted 3-D power Doppler can help doctors decide if a breast mass is cancer or not.